Phibro Animal Health Corporation (PAHC) Receiving Somewhat Favorable News Coverage, Study Finds
Headlines about Phibro Animal Health Corporation (NASDAQ:PAHC) have been trending somewhat positive on Saturday, according to Accern. The research firm identifies positive and negative news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Phibro Animal Health Corporation earned a news sentiment score of 0.13 on Accern’s scale. Accern also gave news articles about the company an impact score of 44.4916282295233 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Here are some of the media stories that may have effected Accern’s rankings:
- Phibro Animal Health Corporation Announces Improvements in OmniGen-AF® Nutritional Specialty Product (newswire.ca)
- Phibro Animal Health Corp : Earnings Review and Free Research Report: Phibro Animal Health’s Net Sales Grew 3%; Adjusted EPS Surged 22% (4-traders.com)
- Phibro Animal Health Corporation (PAHC) Insider Sells $357,000.00 in Stock (americanbankingnews.com)
- Alantra Partners : advised Biotay on its sale to Phibro Animal Health Corporation (4-traders.com)
A number of analysts have weighed in on PAHC shares. Credit Suisse Group lowered shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and raised their target price for the company from $29.00 to $36.00 in a research report on Friday, June 2nd. BidaskClub lowered shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, June 14th. Piper Jaffray Companies set a $35.00 target price on shares of Phibro Animal Health Corporation and gave the company a “buy” rating in a research report on Friday, July 21st. Finally, Bank of America Corporation restated an “underperform” rating and issued a $33.00 target price on shares of Phibro Animal Health Corporation in a research report on Wednesday, August 23rd. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $34.00.
Shares of Phibro Animal Health Corporation (PAHC) traded up 0.14% during trading on Friday, hitting $35.40. 65,288 shares of the stock were exchanged. Phibro Animal Health Corporation has a 52 week low of $24.83 and a 52 week high of $40.25. The firm has a market capitalization of $1.41 billion, a price-to-earnings ratio of 21.99 and a beta of 1.36. The stock’s 50 day moving average price is $37.87 and its 200 day moving average price is $33.97.
Phibro Animal Health Corporation (NASDAQ:PAHC) last released its earnings results on Wednesday, August 30th. The company reported $0.39 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.35 by $0.04. Phibro Animal Health Corporation had a net margin of 8.45% and a return on equity of 47.88%. The company had revenue of $194.84 million for the quarter, compared to analyst estimates of $192.47 million. During the same quarter last year, the firm earned $0.32 EPS. The firm’s quarterly revenue was up 3.0% compared to the same quarter last year. On average, equities analysts predict that Phibro Animal Health Corporation will post $1.56 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 27th. Investors of record on Wednesday, September 6th will be issued a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a dividend yield of 1.13%. The ex-dividend date of this dividend is Friday, September 1st. Phibro Animal Health Corporation’s dividend payout ratio is currently 24.69%.
In related news, major shareholder Bfi Co., Llc sold 48,000 shares of the stock in a transaction on Friday, June 30th. The shares were sold at an average price of $37.42, for a total transaction of $1,796,160.00. Following the transaction, the insider now owns 92,000 shares of the company’s stock, valued at approximately $3,442,640. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, VP Daniel M. Bendheim sold 1,443 shares of the stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $40.05, for a total transaction of $57,792.15. Following the transaction, the vice president now directly owns 300 shares in the company, valued at approximately $12,015. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 404,448 shares of company stock worth $14,756,514. 48.09% of the stock is owned by insiders.
ILLEGAL ACTIVITY NOTICE: This story was first reported by Daily Political and is the sole property of of Daily Political. If you are reading this story on another site, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The original version of this story can be viewed at https://www.dailypolitical.com/2017/09/23/phibro-animal-health-corporation-pahc-receiving-somewhat-favorable-news-coverage-study-finds.html.
Phibro Animal Health Corporation Company Profile
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.